FDA extends use of NovaBay wound cleaner, new spray pump

A wound-cleaning system from NovaBay Pharmaceuticals Inc. was cleared for wider use Monday by the Food and Drug Administration. The NeutroPhase skin and would cleanser and a related spray pump from Emeryville-based NovaBay (AMEX: NBY) were cleared through the FDA's 510(k) process for medical devices. NeutroPhase consists of hypochlorous acid, a common disinfectant, in normal saline.